An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Voice Worries
However, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the service has taken down problematic content and banned associated hashtags and query recommendations. The organization stated it was committed to keeping the platform secure and investing in enhancing compliance measures.
Online Trading Operations
Research also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.
After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or past usage.
Item Details and Pricing
Within these communities, messages display dark colored parcels with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially serious medical dangers”.
